Cwm, LLC Incyte Corp Transaction History

Cwm, LLC

$21.2 Billion
Q2 2024

A detailed history of Cwm, LLC transactions in Incyte Corp stock. As of the latest transaction made, Cwm, LLC holds 7,972 shares of INCY stock, worth $488,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,972

Previous 8,659 7.93%

Holding current value

$488,444

Previous $493,000 2.03%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$51.18 - $63.75 $35,160 - $43,796	-687 Reduced 7.93%	7,972 $483,000
Q1 2024 Apr 05, 2024	BUY	$56.55 - $66.59 $200,978 - $236,660	3,554 Added 69.62%	8,659 $493,000
Q4 2023 Feb 01, 2024	SELL	$52.16 - $64.19 $1,251 - $1,540	-24 Reduced 0.47%	5,105 $321,000
Q3 2023 Oct 11, 2023	BUY	$57.77 - $65.93 $136,337 - $155,594	2,360 Added 85.23%	5,129 $296,000
Q2 2023 Aug 03, 2023	SELL	$60.95 - $75.51 $8,533 - $10,571	-140 Reduced 4.81%	2,769 $172,000
Q1 2023 Apr 28, 2023	BUY	$70.23 - $86.01 $51,197 - $62,701	729 Added 33.44%	2,909 $210,000
Q4 2022 Feb 01, 2023	BUY	$67.18 - $84.11 $4,568 - $5,719	68 Added 3.22%	2,180 $175,000
Q3 2022 Oct 27, 2022	BUY	$66.18 - $82.86 $5,029 - $6,297	76 Added 3.73%	2,112 $141,000
Q2 2022 Jul 28, 2022	BUY	$66.18 - $83.18 $29,516 - $37,098	446 Added 28.05%	2,036 $155,000
Q1 2022 Apr 21, 2022	BUY	$66.02 - $79.71 $59,351 - $71,659	899 Added 130.1%	1,590 $126,000
Q4 2021 Jan 31, 2022	BUY	$63.34 - $74.11 $40,474 - $47,356	639 Added 1228.85%	691 $51,000
Q4 2020 Sep 15, 2021	SELL	$80.74 - $97.7 $5,894 - $7,132	-73 Reduced 58.4%	52 $4,000
Q4 2020 Jan 27, 2021	BUY	$80.74 - $97.7 $5,894 - $7,132	73 Added 140.38%	125 $11,000
Q3 2020 Sep 15, 2021	SELL	$85.07 - $109.69 $8,762 - $11,298	-103 Reduced 66.45%	52 $4,000
Q3 2020 Oct 19, 2020	BUY	$85.07 - $109.69 $8,762 - $11,298	103 Added 198.08%	155 $14,000
Q2 2020 Sep 15, 2021	SELL	$74.18 - $108.93 $5,415 - $7,951	-73 Reduced 58.4%	52 $4,000
Q2 2020 Jul 22, 2020	BUY	$74.18 - $108.93 $5,415 - $7,951	73 Added 140.38%	125 $13,000
Q1 2020 Sep 15, 2021	SELL	$63.18 - $85.97 $4,612 - $6,275	-73 Reduced 58.4%	52 $4,000
Q1 2020 Apr 28, 2020	BUY	$63.18 - $85.97 $4,612 - $6,275	73 Added 140.38%	125 $9,000
Q4 2019 Sep 14, 2021	SELL	$73.04 - $95.72 $2,921 - $3,828	-40 Reduced 43.48%	52 $4,000
Q4 2019 Jan 27, 2020	BUY	$73.04 - $95.72 $2,921 - $3,828	40 Added 76.92%	92 $8,000
Q3 2019 Sep 14, 2021	SELL	$72.82 - $86.52 $1,820 - $2,163	-25 Reduced 32.47%	52 $4,000
Q3 2019 Oct 22, 2019	BUY	$72.82 - $86.52 $1,820 - $2,163	25 Added 48.08%	77 $6,000
Q2 2019 Sep 14, 2021	SELL	$73.52 - $88.7 $5,955 - $7,184	-81 Reduced 60.9%	52 $4,000
Q2 2019 Jul 31, 2019	BUY	$73.52 - $88.7 $5,955 - $7,184	81 Added 155.77%	133 $11,000
Q1 2019 Sep 02, 2021	SELL	$63.56 - $88.17 $5,148 - $7,141	-81 Reduced 60.9%	52 $0
Q1 2019 Apr 22, 2019	BUY	$63.56 - $88.17 $3,750 - $5,202	59 Added 79.73%	133 $11,000
Q4 2018 Jan 25, 2019	BUY	$58.5 - $69.94 $4,329 - $5,175	74 New	74 $5,000
Q1 2018 Apr 26, 2018	SELL	$83.06 - $100.98 $3,903 - $4,746	-47 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$109.15 - $138.27 $5,130 - $6,498	47	47 $5,000

Others Institutions Holding INCY

# of Institutions

629

Shares Held

198M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account